US, WASHINGTON (ORDO NEWS) — The World Health Organization (WHO) has launched a new international initiative aimed at accelerating the development of technologies for the diagnosis and treatment of coronavirus disease. The solemn ceremony on this occasion took place on Friday in Geneva in a teleconference mode with the participation of representatives of several international structures and states.
Opening the videoconference, WHO Director-General Tedros Adan Gebreyesus warmly thanked European Commission President Ursula von der Leyen, French President Emmanuel Macron, as well as philanthropists Bill and Melinda Gates for their participation in the initiative.
“We are facing a common threat, we can overcome it only by acting together,” said the head of WHO, stressing that the world “urgently needs” effective means to combat the pandemic.
The UN Secretary General, António Guterres, speaking at the ceremony, recalled that the coronavirus knows no boundaries and threatens people everywhere. “In an interdependent world, none of us is safe until we are all safe,” he said, expressing confidence that acting together, humanity will emerge stronger from the current pandemic.
As previously explained by WHO, the new initiative is “a global partnership and collaboration to accelerate the development, production and use of safe and effective technologies for the prevention, diagnosis and treatment of COVID-19.” These technologies should be made available “to all who need them, around the world.”
Earlier, Tedros Adan Gebreyesus has repeatedly called on countries to actively cooperate in the fight against the pandemic. At a briefing in Geneva on April 20, he announced that more than 100 countries had already joined the international program of tests (Solidarity Trial) of therapeutic agents against coronavirus. For these studies, he said, 1,200 patients were selected.
The outbreak caused by the new coronavirus disease was recorded at the end of 2019 in Central China, spread to most countries and was recognized by the WHO as a pandemic.
Contact us: [email protected]